Jia Jie Biomedical Co Ltd (4109) — Cash Flow Reinvestment Rate
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Reinvestment Rate of 3.87x as of December 2025, reinvesting NT$43.81 Million (capex NT$28.47 Million plus investments NT$15.34 Million) from operating cash flow of NT$11.32 Million. Explore Jia Jie Biomedical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jia Jie Biomedical Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Jia Jie Biomedical Co Ltd across 6 annual periods. Also explore Jia Jie Biomedical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Jia Jie Biomedical Co Ltd. For live market cap and broader valuation context, see market value of Jia Jie Biomedical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.62x | NT$184.01 Million | NT$21.34 Million | NT$85.50 Million | ▲ +336.0% |
| 2024 | 1.98x | NT$87.70 Million | NT$44.35 Million | NT$19.63 Million | ▼ -94.8% |
| 2021 | 37.72x | NT$164.94 Million | NT$4.37 Million | NT$1.52 Million | ▲ +519.3% |
| 2020 | 6.09x | NT$165.05 Million | NT$27.10 Million | NT$1.63 Million | ▼ -15.8% |
| 2019 | 7.23x | NT$178.78 Million | NT$24.71 Million | NT$3.05 Million | ▲ +114.6% |
| 2015 | 3.37x | NT$277.22 Million | NT$82.22 Million | NT$273.85 Million | — |